2016-12-19T13:56:23-06:00 2016-03-31 521511275 RAFFA PC 1899 L STREET NW SUITE 850 WASHINGTON DC 20036 990 2015-04-01 760514428 MELANOMA RESEARCH FOUNDATION MELA 8006731290 1411 K STREET NW NO 800 WASHINGTON DC 20005 TIMOTHY TURNHAM EXECUTIVE DIRECTOR 8006731290 2016-12-19 1 FRANK H SMITH P00639053 2028225000 2016-12-19 2015 2017-02-10 21:41:12Z X TIMOTHY TURNHAM 1411 K STREET NW NO 800 WASHINGTON DC 20005 5853294 0 X WWW.MELANOMA.ORG X 1996 TX FUND RESEARCH FOR A CURE, EDUCATE/RAISE AWARENESS & ACT AS AN ADVOCATE FOR MELANOMA COMMUNITY. 15 14 23 1000 0 0 385408 5736841 0 12500 68 84 10359 -135438 395835 5613987 80607 1327525 0 0 328685 1717780 0 235344 521528 606996 2459779 1016288 5740428 -620453 -126441 1140201 1152441 1062045 2080513 78156 -928072 X THE MELANOMA RESEARCH FOUNDATION (MRF)SUPPORTS MEDICAL RESEARCH FOR FINDING EFFECTIVE TREATMENTS AND EVENTUALLY A CURE FOR MELANOMA; EDUCATES PATIENTS AND PHYSICIANS ABOUT DIAGNOSIS AND TREATMENT OF MELANOMA; AND ACTS AS AN ADVOCATE FOR THE MELANOMA COMMUNITY TO RAISE THE AWARENESS OF THIS CANCER. 0 0 1922357 1326675 RESEARCH - TO FUND MELANOMA RESEARCH AND SUPPORT DOCTORS AND RESEARCHERS WHO ARE WORKING TO FIND A CURE FOR THIS DEADLY SKIN CANCER. CURRENTLY, MRF FUNDS FIRST AND SECOND-YEAR CAREER DEVELOPMENT AWARDS, FIRST AND SECOND-YEAR ESTABLISHED INVESTIGATOR AWARDS, AND MEDICAL STUDENT AWARDS IN DERMATOLOGY. 1596952 850 12500 EDUCATION - MRF BELIEVES THAT PATIENTS WHO ARE WELL-INFORMED AND WELL-SUPPORTED LIVE LONGER AND BETTER. MRF PROVIDES LIVE PATIENT SYMPOSIA LED BY MELANOMA EXPERTS, HOSTS THE LARGEST ONLINE COMMUNITY OF MELANOMA PATIENTS IN THE WORLD, OFFERS A TOLL-FREE HELP LINE FOR PATIENTS AND FAMILIES, RUNS A STATE-OF THE-ART CLINICAL TRIALS FINDER AND PROVIDES A WIDE ARRAY OF PRINT AND ONLINE EDUCATIONAL MATERIALS. 1174145 ADVOCACY - MRF IS DEDICATED TO RAISING AWARENESS OF MELANOMA WITH THE GOAL OF PROMOTING BOTH PRIMARY PREVENTION AND EARLY DETECTION. WORKING WITH A LARGE AND GROWING NETWORK OF GRASSROOTS VOLUNTEERS AND HIGH-PROFILE STRATEGIC PARTNERS, MRF IS ACTIVELY ENGAGED IN COMBATING THE RISING INCIDENCE OF MELANOMA. IN 2011, THE MRF BEGAN RAISING AWARENESS AND FUNDS FOR OCULAR MELANOMA THROUGH ITS CURE OM (THE COMMUNITY UNITED FOR RESEARCH AND EDUCATION OF OCULAR MELANOMA) INITIATIVE. 4693454 1 1 0 1 0 0 0 0 0 0 1 0 0 1 1 1 0 1 0 0 0 0 0 1 1 0 0 1 1 1 0 0 0 0 0 0 0 1 0 0 0 0 0 1 1 1 0 0 1 100 0 1 23 1 0 0 0 0 0 1 1 0 0 0 0 X 15 14 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 AL AK AZ AR CA CO CT FL GA HI IL KS KY MA MD ME MI MN MS NC ND NH NJ NM NY OH OK OR PA RI UT VA WA WI WV TN SC X TIMOTHY TURNHAM PHD 8006731290 1411 K STREET NW NO 800 WASHINGTON DC 20005 STEVE SILVERSTEIN CHAIR 2.00 X X 0 0 0 JEFFREY HARRIS VICE CHAIR 2.00 X X 0 0 0 GEORGE P JAMESON TREASURER 2.00 X X 0 0 0 JOE FAZIO SECRETARY 2.00 X X 0 0 0 STAN ADLER BOARD MEMBER 1.00 X 0 0 0 MICHAEL B ATKINS MD BOARD MEMBER 1.00 1.00 X 0 0 0 REBECCA K DREMAN BOARD MEMBER 1.00 X 0 0 0 TUCKER ESKEW BOARD MEMBER 1.00 X 0 0 0 ANTHONY T HENDRICKSON BOARD MEMBER 1.00 1.00 X 0 0 0 RANDY LOMAX MA MFT BOARD MEMBER 1.00 1.00 X 0 0 0 CHAD MACDONALD BOARD MEMBER 1.00 X 0 0 0 WILLIAM G REILLY BOARD MEMBER 1.00 X 0 0 0 ZE'EV A RONAI PHD BOARD MEMBER 1.00 1.00 X 0 0 0 CHERYL STRATORS BOARD MEMBER 1.00 X 0 0 0 MARK WEINZIERL BOARD MEMBER 1.00 X 0 0 0 TIMOTHY TURNHAM PHD EXECUTIVE DIRECTOR 40.00 X 180083 0 17678 180083 0 17678 1 0 1 0 JONES PUBLIC AFFAIRS 1420 K STREET NW SUITE 1050 WASHINGTON DC 20005 COMMUNICATIONS 188242 POWERED BY PROFESSIONALS 1460 BROADWAY NEW YORK NY 10026 FUNDRAISING SERVICES 139254 2 109475 985547 4641819 3966 5736841 CONTRACT REVENUE 900099 12500 12500 12500 145 145 4089 4150 -61 -61 -61 89030 985547 235157 -146127 -146127 6700 0 6700 6700 OTHER 900099 3989 3989 3989 5613987 12500 0 -135354 1305525 1305525 22000 22000 218737 52497 118118 48122 1230590 1063929 54184 112477 26423 23322 784 2317 127911 106253 9074 12584 114119 88667 12963 12489 161990 138727 23263 60129 60129 235344 235344 81580 52641 28939 10654 6830 3824 949440 777243 110166 62031 258614 161931 96683 92478 69472 13824 9182 278736 241108 14271 23357 386194 381806 2897 1491 20030 14675 3221 2134 13205 8466 4739 RECOGNITION/AWARDS 79067 79067 RECRUITMENT 19793 12689 7104 MERCHANDISE 17761 17761 BOOKS/SUBSCRIPT./DUES 16513 16513 13595 8716 4879 5740428 4693454 525446 521528 0 233917 276081 75207 644084 579241 155078 140847 379722 337499 46435 42223 5155 8934 13368 72072 1140201 1152441 506206 381880 33333 1472916 248799 273707 225717 1062045 2080513 X -596669 -2095773 674825 1167701 78156 -928072 1140201 1152441 X -126441 -120 -890017 10350 X 0 1 X 1 0 X 4948382 4874503 5729925 385408 5736841 21675059 4948382 4874503 5729925 385408 5736841 21675059 963821 20711238 20 4903 16905 68 145 22041 6675 45000 58764 3989 114428 21811528 372071 0.94960 0.95860 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: OTHER - 2011 AMOUNT: $ 6,675. 2012 AMOUNT: $ 45,000. 2013 AMOUNT: $ 58,764. 2014 AMOUNT: $ 0. 2015 AMOUNT: $ 3,989. SCHEDULE A, PART II, COLUMN (D): DUE TO A CHANGE IN ACCOUNTING PERIOD, MRF FILED A 2015 SHORT YEAR RETURN FOR THE PERIOD OF JANUARY 1, 2015 TO MARCH 31, 2015 WHICH IS REFLECTED IN THE 2014 COLUMN. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 1 0 0 0 0 0 0 1 60129 60129 0 PART II-B, LINE 1: A LOBBYING FIRM WAS RETAINED TO ASSIST MRF IN DEVELOPING, COORDINATING AND IMPLEMENTING A FEDERAL ADVOCACY PLAN TO INCREASE AWARENESS OF SKIN CANCER PREVENTION AND MELANOMA, AND TO INCREASE FEDERAL FUNDING FOR SKIN CANCER PREVENTION AND MELANOMA RESEARCH AT THE DEPARTMENTS OF HEALTH AND HUMAN SERVICES, DEFENSE, THE ENVIRONMENTAL PROTECTION AGENCY, AND OTHER RELEVANT AGENCIES. 5690 2841 2849 343544 316016 27528 30488 18642 11846 42223 DEPOSITS 44148 DUE FROM AFFILIATE 27924 72072 DEFERRED RENT 12906 DUE TO AFFILIATE 212811 225717 X PART X, LINE 2: MRF PERFORMED AN EVALUATION OF UNCERTAIN TAX POSITIONS FOR THE YEAR ENDED MARCH 31, 2016, AND DETERMINED THAT THERE WERE NO MATTERS THAT WOULD REQUIRE RECOGNITION IN THE FINANCIAL STATEMENTS OR THAT MAY HAVE ANY EFFECT ON ITS TAX-EXEMPT STATUS. X X X X X X 1 POWERED BY PROFESSIONALS INC 1375 BROADWAY NEW YORK NY 10018 FUNDRAISING SERVICES 0 812431 140746 671685 GLATZ MANAGEMENT SERVICES 19244 S BLACKHAWK PARKWAY MOKENA IL 60448 FUNDRAISING SERVICES 0 98926 20000 78926 BING CONSULTING 3361 MISSION STREET SAN FRANCISCO CA 94110 FUNDRAISING SERVICES 0 91715 29598 62117 BOWER CONSULTING PO BOX 1839 PHILADELPHIA PA 19105 FUNDRAISING SERVICES 0 71505 45000 26505 1074577 235344 839233 AK AL AR AZ CA CO CT FL GA HI IL KS KY NC ND NH NJ NM NY OH OK OR PA RI SC TN UT VA WA WI WV ME MD MS MA MI MN DC GALA - NEW YORK 546445 506265 40180 58421 4400 2485 GALA - DENVER 258213 243413 14800 1000 18988 1697 14639 3 269919 235869 34050 10249 82323 11188 29767 1074577 985547 89030 11249 159732 17285 46891 235157 -146127 1 BROAD INSTITUTE INC CAMBRIDGE CENTER CAMBRIDGE MA 02115 263428781 501(C)(3) 50000 TO SUPPORT RESEARCH FOR MELANOMA CANCER H LEE MOFFIT CANCER CANCER AND RESEARCH INSTITUTE 12902 MAGNOLIA DRIVE TAMPA FL 33612 592451713 501(C)(3) 50000 TO SUPPORT RESEARCH FOR MELANOMA CANCER ICAHN SCHOOL OF MEDICINE AT MT SINAI PO BOX 1075 NEW YORK NY 10029 136171197 501(C)(3) 250000 TO SUPPORT RESEARCH FOR MELANOMA CANCER SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE 90901 NORTH TORREY PINES ROAD LA JOLLA CA 92037 510197108 501(C)(3) 50000 TO SUPPORT RESEARCH FOR MELANOMA CANCER THE WISTAR INSTITUTE 3601 SPRUCE STREET PHILADELPHIA PA 19104 236434390 501(C)(3) 150000 TO SUPPORT RESEARCH FOR MELANOMA CANCER UCLA MEDICAL CENTER 757 WESTWOOD PLAZA LOS ANGELES CA 90095 956006143 501(C)(3) 150000 TO SUPPORT RESEARCH FOR MELANOMA CANCER UNIVERSITY OF PENNSYLVANIA 3451 WALNUT STREET FRANKLIN BLDG PHILADELPHIA PA 19104 231352685 501(C)(3) 50000 TO SUPPORT RESEARCH FOR MELANOMA CANCER YALE UNIVERSITY 47 COLLEGE STREET SUITE 203 NEW HAVEN CT 06520 060646973 501(C)(3) 100000 TO SUPPORT RESEARCH FOR MELANOMA CANCER TEMPLE UNIVERSITY 1805 N BROAD STREET PHILADELPHIA PA 19122 231365971 501(C)(3) 50000 TO SUPPORT RESEARCH FOR MELANOMA CANCER UNIVERSITY OF TEXAS 110 INNER CAMPUS DRIVE AUSTIN TX 78705 746000203 501(C)(3) 250000 TO SUPPORT RESEARCH FOR MELANOMA CANCER THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 1111 FRANKLIN STREET 12TH FLOOR OAKLAND CA 94607 943067788 501(C)(3) 50000 TO SUPPORT RESEARCH FOR MELANOMA CANCER MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM INC 1411 K STREET SUITE 800 WASHINGTON DC 20005 800671049 501(C)(3) 100525 TO SUPPORT RESEARCH FOR MELANOMA CANCER 12 0 STUDENT AWARDS 6 22000 PART I, LINE 2: THE SCIENTIFIC ADVISORY COMMITTEE OF THE MRF CLOSELY MONITORS GRANT FUND USAGE. PHYSICIANS AND SCIENTISTS FROM WORLD-RENOWNED EDUCATIONAL AND RESEARCH INSTITUTIONS MAKE UP THE ADVISORY MEMBERSHIP. FINANCIAL AND SCIENTIFIC PROGRESS REPORTS ARE SUBMITTED TO THE MRF AFTER THE FIRST YEAR OF THE GRANTING PERIOD. FULL FINANCIAL AND SCIENTIFIC REPORTS DETAILING ALL ACTIVITIES DURING THE GRANTING PERIOD ARE SUBMITTED WITHIN 60 DAYS OF THE END OF THE GRANTING PERIOD (EVEN IF A NO-COST EXTENSION IS REQUESTED). ACKNOWLEDGEMENT OF SUPPORT FROM THE MRF IS INCLUDED IN ANY PUBLISHED REPORT PERTAINING TO FINDINGS RESULTING FROM RESEARCH CONDUCTED UNDER THE GRANT AWARD. 1 X X X 0 0 0 0 0 0 0 0 0 TIMOTHY TURNHAM PHD EXECUTIVE DIRECTOR 180083 0 0 0 0 0 5200 0 12478 0 197761 0 0 0 STAN ADLER ASSOCIATES STAN ADLER, BOARD MEMBER, IS ALSO THE CHAIR AND FOUNDER OF THE ASSOCIATES 72000 MRF PAID A RETAINER FEE TO THE ASSOCIATES FOR GRAPHIC DESIGN AND MARKETING SERVICES. 0 FORM 990, PART VI, SECTION B, LINE 11 MRF HIRES AN INDEPENDENT ACCOUNTING FIRM TO PREPARE THE FEDERAL FORM 990. UPON SUBMISSION OF THE FINAL DRAFT, THE FORM 990 IS DISTRIBUTED TO THE BOARD OF DIRECTORS AND THE FINANCE COMMITTEE FOR THEIR REVIEW PRIOR TO FILING WITH THE INTERNAL REVENUE SERVICE. FORM 990, PART VI, SECTION B, LINE 12C THE CONFLICT OF INTEREST POLICY IS DISTRIBUTED ANNUALLY TO ALL MEMBERS OF THE BOARD OF DIRECTORS, KEY PERSONNEL, AND COMMITTEE MEMBERS. EACH RECIPIENT OF THE POLICY RETURNS A SIGNED AND DATED RESPONSE FORM INDICATING THEY REVIEWED THE POLICY WHILE NOTING IF ANY CONFLICTS EXIST. FOLLOWING THE FULL DISCLOSURE OF A POSSIBLE CONFLICT OF INTEREST DURING THE YEAR, THE BOARD OF DIRECTORS WILL DETERMINE WHETHER A CONFLICT OF INTEREST EXISTS AND THE BOARD MEMBER WITH THE POSSIBLE CONFLICT WILL RECUSE HIMSELF OR HERSELF FROM THE DISCUSSION AND VOTE. FORM 990, PART VI, SECTION B, LINE 15A COMPENSATION FOR THE EXECUTIVE DIRECTOR IS DETERMINED IN THE EXECUTIVE SESSION OF A BOARD OF DIRECTORS MEETING AND IS BASED UPON COMPARABLE SALARY DATA. THE BOARD OF DIRECTORS CONVENED AN AD HOC COMPENSATION COMMITTEE THAT CONTRACTED WITH AN OUTSIDE EXPERT IN SALARY EVALUATION. THIS OUTSIDE GROUP LOOKED AT THE SALARIES OF ALL MRF MANAGEMENT AND COMPARED THOSE SALARIES WITH INDUSTRY STANDARDS, ADJUSTED FOR REGIONAL VARIATIONS. APPROPRIATE ADJUSTMENTS WERE MADE TO ENSURE THAT MRF SALARIES ARE IN KEEPING WITH BEST PRACTICES. THE LAST COMPENSATION REVIEW FOR THE EXECUTIVE DIRECTOR WAS CONDUCTED IN THE FALL OF 2015. COMPENSATION FOR STAFF IS DETERMINED BY THE EXECUTIVE DIRECTOR AND OFFICE MANAGER USING COMPARABILITY DATA DERIVED FROM SALARY SURVEYS FOR SPECIFIC POSITIONS. CONTEMPORANEOUS DOCUMENTATION IS KEPT REGARDING DELIBERATIONS AND DECISIONS. FORM 990, PART VI, SECTION C, LINE 19 MRF'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART XI, LINE 9: REFUND OF GRANT 10,350. MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM INC 1411 K STREET SUITE 800 WASHINGTON DC 20005 800671049 TO ORGANIZE, CONDUCT, AND SUPPORT CLINICAL TRIALS DC 501(C)(3) LINE 11A, I MELANOMA RESEARCH FOUNDATION 1 0 1 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM INC B 100525 COST